Alloreactivity Across HLA Barriers Is Mediated by Both Naïve and Antigen-Experienced T Cells

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 6, 2011, Pages 800-809

  Melenhorst, J Joseph ^a   Scheinberg, Phillip ^a,b   Williams, Ann ^a   Ambrozak, David R ^b   Keyvanfar, Keyvan ^a   Smith, Melody ^a   McCoy, J Philip ^a   Hensel, Nancy F ^a   Douek, Daniel C ^b   Barrett, A John ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Clonotype; Cross reactivity; Graft versus host disease

Indexed keywords

HLA ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ARTICLE; DNA VIRUS; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; MEMORY T LYMPHOCYTE; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; CYTOKINES; CYTOMEGALOVIRUS; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HERPESVIRUS 4, HUMAN; HLA ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; PREGNANCY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE ANALYSIS, DNA;

EID: 79955989170     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.12.711     Document Type: Article

References (60)

1. Suchin E.J., Langmuir P.B., Palmer E., et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 2001, 166:973-981.
2. Bevan M.J. High determinant density may explain the phenomenon of alloreactivity. Immunol Today 1984, 5:128-130.
3. Matzinger P., Bevan M.J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?. Cell Immunol 1977, 29:1-5.
4. Lombardi G., Sidhu S., Lamb J.R., et al. Co-recognition of endogenous antigens with HLA-DR1 by alloreactive human T cell clones. J Immunol 1989, 142:753-759.
5. Heath W.R., Hurd M.E., Carbone F.R., et al. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature 1989, 341:749-752.
6. Wang W., Man S., Gulden P.H., et al. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J Immunol 1998, 160:1091-1097.
7. Obst R., Munz C., Stevanovic S., et al. Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allo-restricted T cell repertoire. Eur J Immunol 1998, 28:2432-2443.
8. Whitelegg A.M., Oosten L.E., Jordan S., et al. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers. J Immunol 2005, 175:1706-1714.
9. Felix N.J., Donermeyer D.L., Horvath S., et al. Alloreactive T cells respond specifically to multiple distinct peptide MHC complexes. Nat Immunol 2007, 8:388-397.
10. Song E.S., Linsk R., Olson C.A., et al. Allospecific cytotoxic T lymphocytes recognize an H2 peptide in the context of a murine major histocompatibility complex class I molecule. Proc Natl Acad Sci U S A 1988, 85:1927-1931.
11. de Koster H.S., Anderson D.C., Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med 1989, 169:1191-1196.
12. Liu Z., Sun Y.K., Xi Y.P., et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993, 177:1643-1650.
13. Valujskikh A., Matesic D., Gilliam A., et al. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998, 101:1398-1407.
14. Anderson B.E., McNiff J., Yan J., et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 2003, 112:101-108.
15. Chen B.J., Cui X., Sempowski G.D., et al. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 2004, 103:1534-1541.
16. Chen B.J., Deoliveira D., Cui X., et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood 2007, 109:3115-3123.
17. Zheng H., Matte-Martone C., Li H., et al. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood 2008, 111:2476-2484.
18. Zheng H., Matte-Martone C., Jain D., et al. Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia. J Immunol 2009, 182:5938-5948.
19. Brehm M.A., Daniels K.A., Priyadharshini B., et al. Allografts stimulate cross-reactive virus-specific memory CD8 T cells with private specificity. Am J Transplant 2010, 10:1738-1748.
20. Brehm M.A., Mangada J., Markees T.G., et al. Rapid quantification of naive alloreactive T cells by TNF-alpha production and correlation with allograft rejection in mice. Blood 2007, 109:819-826.
21. Gaston J.S., Rickinson A.B., Epstein M.A. Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants. J Exp Med 1983, 158:1804-1821.
22. Strang G., Rickinson A.B. Multiple HLA class I-dependent cytotoxicities constitute the " non-HLA-restricted" response in infectious mononucleosis. Eur J Immunol 1987, 17:1007-1013.
23. Richert J.R., Robinson E.D., Reuben-Burnside C.A., et al. Measles virus-specific human T cell clones: studies of alloreactivity and antigenic cross-reactivity. J Neuroimmunol 1988, 19:59-68.
24. Burrows S.R., Khanna R., Burrows J.M., et al. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 1994, 179:1155-1161.
25. Kuzushima K., Sun R., van Bleek G.M., et al. The role of self peptides in the allogeneic cross-reactivity of CTLs. J Immunol 1995, 155:594-601.
26. Reichstetter S., Standifer N.E., Geubtner K.A., et al. Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+ cell clones show alloreactivity to DQ0601. Immunology 2006, 117:350-357.
27. Elkington R., Khanna R. Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: implications for graft-versus-host disease. Blood 2005, 105:1362-1364.
28. Landais E., Morice A., Long H.M., et al. EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses. J Immunol 2006, 177:1427-1433.
29. Weekes M.P., Carmichael A.J., Wills M.R., et al. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol 1999, 162:7569-7757.
30. Hoshino Y., Morishima T., Kimura H., et al. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. J Immunol 1999, 163:5735-5740.
31. Sylwester A.W., Mitchell B.L., Edgar J.B., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005, 202:673-685.
32. Pourgheysari B., Khan N., Best D., et al. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 2007, 81:7759-7765.
33. Gratama J.W., Zwaan F.E., Stijnen T., et al. Herpes virus immunity and acute graft-versus-host disease. Lancet 1987, 1:471-474.
34. Bostrom L., Ringden O., Forsgren M. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease. Scand J Immunol 1991, 34:45-52.
35. Melenhorst J.J., Scheinberg P., Chattopadhyay P.K., et al. High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow. Blood 2009, 113:2238-2244.
36. Melenhorst J.J., Scheinberg P., Lu J., et al. Regulatory T-cell depletion does not prevent emergence of new CD25+FOXP3+ lymphocytes after antigen stimulation in culture. Cytotherapy 2008, 10:152-164.
37. Melenhorst J.J., Solomon S.R., Shenoy A., et al. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen-presenting cells. J Immunother 2006, 29:436-443.
38. Scheinberg P., Melenhorst J.J., Hill B.J., et al. The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements. J Immunol Methods 2007, 321:107-120.
39. Szabolcs P., Park K.D., Reese M., et al. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol 2003, 31:708-714.
40. Appay V., van Lier R.A., Sallusto F., et al. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73:975-983.
41. Lefrancois L., Klein J.R., Paetkau V., et al. Antigen-independent activation of memory cytotoxic T cells by interleukin 2. J Immunol 1984, 132:1845-1850.
42. Gagliardi M.C., De Petrillo G., Salemi S., et al. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int Immunol 1995, 7:1741-1752.
43. Douek D.C., Betts M.R., Brenchley J.M., et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol 2002, 168:3099-3104.
44. Amir A.L., D'Orsogna L.J., Roelen D.L., et al. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010, 115:3146-3157.
45. D'Orsogna L.J., Roelen D.L., Doxiadis, et al. Alloreactivity from human viral-specific memory T cells. Transpl Immunol 2010, 23:149-155.
46. Foster A.E., Marangolo M., Sartor M.M., et al. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. Blood 2004, 104:2403-2409.
47. Rickinson AB, Fieff, E. Epstein-Barr virus. In: Knipe DM, Howley, PM, eds. Fields Virology, Vol 2. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:2575-2627.
48. Mocarski ES J, Courcelle CT. Cytomegaloviruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology, Fourth edition, Philadelphia, PA: Lippincott Williams & Wilkins, 2001: 2629-2673.
49. Burrows S.R., Silins S.L., Khanna R., et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 1997, 27:1726-1736.
50. Hislop A.D., Taylor G.S., Sauce D., et al. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007, 25:587-617.
51. Scheinberg P., Melenhorst J.J., Brenchley J.M., et al. The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor. Blood 2009, 114:5071-5080.
52. Venturi V., Chin H.Y., Asher T.E., et al. TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV. J Immunol 2008, 181:7853-7862.
53. Leen A.M., Christin A., Myers G.D., et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 2009, 114:4283-4292.
54. O'Reilly R.J., Doubrovina E., Trivedi D., et al. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunol Res 2007, 38:237-250.
55. Anderson B.E., Zheng H., Taylor P.A., et al. Memory T cells in GVHD and GVL. Biol Blood Marrow Transplant 2008, 14(1 Suppl. 1):19-20.
56. Warren E.H., Fujii N., Akatsuka Y., et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood 2010, 115:3869-3878.
57. Burrows S.R., Silins S.L., Moss D.J., et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 1995, 182:1703-1715.
58. Saliba R.M., de Lima M., Giralt S., et al. Hyperacute GVHD: risk factors, outcomes, and clinical implications. Blood 2007, 109:2751-2758.
59. Brenchley J.M., Karandikar N.J., Betts M.R., et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003, 101:2711-2720.
60. Melenhorst J.J., Brummendorf T.H., Kirby M., et al. CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis. Leuk Res 2001, 25:699-708.